Ibrahim B. Dagher serves as Executive at BRAINSTORM CELL THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Ibrahim B. Dagher has executed 1 insider transactions totaling $22.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 19, 2024 involved selling 63,000 shares valued at $22.1K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 19, 2024 | BCLI | $22.1K | Sale | 63,000 | $0.35 | Discretionary |
Ibrahim B. Dagher currently holds 0 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ibrahim B. Dagher has been a net seller of BCLI stock. They have purchased $0 and sold $22.1K worth of shares.
Ibrahim B. Dagher's most recent insider trade was on Jul 19, 2024, when they sold 63,000 shares at $0.35 per share.
Get notified when new Form 4 filings are submitted